https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
Khandpur
President and CEO
2024
Performance &
Highlights
Sales: $3.24B
+3%
GAAP EPS: $1.84
Adjusted EPS(1): $2.66
+13%
Adjusted EBITDA(1): $526M
+5%
Adjusted EBITDA Margin(1): 16.2%
+20bps
Dividend Increase:
14 Consecutive Years
Great Place to Work® Certification
6 Consecutive Years
(1)Reconciliations of these measures to the
most directly comparable generally accepted
accounting principles (GAAP) financial
measures are included in this annual report on a
supplemental page that follows the Form 10-K.
Annual Report | 2024 2
STOCK EXCHANGE LISTING
Avient's Common Stock is listed on the New York Stock Exchange, Symbol: AVNT
SHAREHOLDER INQUIRIES
If you have any questions concerning your account as a shareholder, name or address
changes, inquiries regarding stock certificates, or if you need tax information regarding
your account, please contact our transfer agent:
Equiniti Trust Company, LLC
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
Phone: 1-855-598-2615
or 1-651-450-4064
www.shareowneronline.com
Additional information about Avient, including current and historic copies of Annual
Reports on Form 10-K and other reports filed with the Securities and Exchange
Commission, is available online at www.avient.com or free of charge from:
Investor Relations
Avient Corporation
33587 Walker Road
Avon Lake, Ohio 44012
Phone: 1-440-930-1000
ANNUAL MEETING
The annual meeting of Avient will be held virtually via live webcast at 9:00 a.m.
https://www.avient.com/sites/default/files/2021-06/plastisol-storage-handling-technical-bulletin.pdf
As a result of these plastisol aging characteristics
and the potential differences in testing
methodology, it is strongly recommended that
incoming quality control (QC) specifications not
be established based on plastisol Technical Data
Sheets (TDS), or Certificates of Analysis (COA).
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-port-a4.pdf
Registre e
documente em seus arquivos qual é a fonte das suas
informações sobre os concorrentes (caso o contexto
já não deixe isso claro).
Quanto mais
potencialmente danosa for uma ação ou
declaração, maior será a probabilidade de que
mais alguém a registre ou se lembre dela.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
Microsoft Word - 2016 Proxy - Final.docx
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the RegistrantR
Filed by a Party other than the Registrant £
Check the appropriate box:
£ Preliminary Proxy Statement
£ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
R Definitive Proxy Statement
£ Definitive Additional Materials
£ Soliciting Material Pursuant to Rule 14a-12
POLYONE CORPORATION
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
R No fee required
Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing
Name
Executive Contributions
FY 2006 – 2014
($)
Registrant Contributions
FY 2006 – 2014
($)
R.M.
https://www.avient.com/sites/default/files/2021-05/avient-colorants-thailand-certificate-of-incorporation-name-change-may-17-2021.pdf
https://www.avient.com/sites/default/files/2021-05/certificate-of-change-of-name-avient-colorants-uk-ltd-may-14-2021.pdf
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
FX +8.5%
FX -0.4%
Total Avient +8.1%
Note: Regional Sales Percentages exclude impact of foreign exchange
COLOR, ADDITIVES & INKS SEGMENT
$487
$522
$89
$97
(in millions) (in millions)
10
+ 7%
(+8% excluding FX)
+ 9%
(+11% excluding FX)
18.3%
+40 bps *18.7%
*
* Adjusted EBITDA Margin %
• Sales growth driven by winning
new product specifications in
consumer & packaging, strong
underlying demand in healthcare
and improving demand in building
& construction
• Favorable mix and raw material
deflation contributed to EBITDA
margin expansion
SPECIALTY ENGINEERED MATERIALS SEGMENT
$268
$295
$51
$57
(in millions) (in millions)
11
• Sales growth driven by restocking
in healthcare & consumer end
markets and strong underlying
demand for composite
applications used in building &
construction, energy and defense
end markets
• Favorable mix contributed to
EBITDA margin expansion
+ 10%
(+10% excluding FX)
+ 12%
(+13% excluding FX)
19.0%
+40 bps *19.4%
*
* Adjusted EBITDA Margin %
2024 G U IDA N CE
FY 2024 GUIDANCE
Previous (Aug 6) Current
Adjusted EPS $2.55 to $2.70 $2.63 to $2.67
Adjusted EBITDA $515 to $540 million $525 to $530 million
Interest Expense $105 million $104 million
Adjusted Effective Tax Rate 23% to 25% 23% to 25%
Capital Expenditures &
Investment in S/4 Hana
~$140 million ~$140 million
13
14
• Investor Day to be held December 4, 2024 at
the NYSE, beginning at 10AM
• The focus will be to do a deep dive on the
Company’s strategy
• Registration available at
www.avient.com/investors
2024 AVIENT INVESTOR DAY
AP P EN D IX
17
Performance
Additives
15%
Pigments
TiO2
Dyestuffs
Polyethylene
10%Nylon
Polypropylene
Styrenic Block
Copolymer
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
19%
23%Industrial
Building and
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
19
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2023 REVENUE | $2 .0 B ILL ION
34%
37%
21%
END MARKET REGION
20
34%
21%
15%
Building &
1% Energy
COLOR, ADDITIVES & INKS
2023 REVENUE | $1 .1 B ILL ION
52%
35%
21
6%Industrial
12%
10% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
26%
Building &
6%
2% Defense
1%
(18% of sales)
2023 AVIENT REGIONAL SALES
25%
Building &
(36% of sales)Transportation
22%
Building &
12%
6%
US &
Canada
(41% of sales)
59%
22%
Building &
LATAM
(5% of sales)
22
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-05/3b - Corporate Governance Guidelines.Draft Feb. 2024.v1.2.Revised.4-16-24.Final_.pdf
Policy of the Board of Directors Relating to Majority Voting
It is a policy of the Board that any nominee for director who receives a greater number of
votes “withheld” from his or her election than votes “for” his or her election (a “Majority
Withheld Vote”) in an election of directors that is not a contested election is expected to
tender his or her resignation as a director to the Board promptly following the
certification of the election results.
The Board will act on each tendered resignation, taking into account the Governance and
Corporate Responsibility Committee’s recommendation, within 90 days following the
certification of the election results.
https://www.avient.com/sites/default/files/2023-06/Terms and Conditions of Sale for the Netherlands.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms
at the time of shipment to a Certificate of Analysis, a Certificate of
Compliance, or a Product Specification Sheet, if any such document
exists, and other specifications signed by Seller (“Specifications”).
https://www.avient.com/sites/default/files/2023-06/Terms and Conditions of Sale for the U.S.%5B17%5D.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms
at the time of shipment to a Certificate of Analysis, a Certificate of
Compliance, or a Product Specification Sheet, if any such document
exists, and other specifications signed by Seller (“Specifications”).